Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Comparison of [177Lu-DOTA… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Comparison of [177Lu-DOTA0,Tyr3]-octreotate and [177Lu-DOTA0,Tyr3]-octreotide for receptor-mediated radiation therapy of the xenografted human midgut carcinoid tumor GOT1.

Artikel i vetenskaplig tidskrift
Författare Christina Swärd
Peter Bernhardt
Viktor Johanson
Anneli Schmitt
Håkan Ahlman
Mats Stridsberg
Eva Forssell-Aronsson
Ola Nilsson
Lars Kölby
Publicerad i Cancer biotherapy & radiopharmaceuticals
Volym 23
Nummer/häfte 1
Sidor 114-20
ISSN 1084-9785
Publiceringsår 2008
Publicerad vid Institutionen för biomedicin, avdelningen för patologi
Institutionen för fysik (GU)
Institutionen för kliniska vetenskaper
Sidor 114-20
Språk en
Länkar dx.doi.org/10.1089/cbr.2007.0421
Ämnesord Animals, Carcinoid Tumor, radiotherapy, Chromogranin A, blood, Humans, Intestinal Neoplasms, radiotherapy, Lutetium, therapeutic use, Mice, Mice, Nude, Octreotide, analogs & derivatives, therapeutic use, Organometallic Compounds, therapeutic use, Radiotherapy Dosage, Receptors, Somatostatin, metabolism, Tumor Cells, Cultured, Xenograft Model Antitumor Assays
Ämneskategorier Medicin och Hälsovetenskap, Radiofysik

Sammanfattning

The aim of this study was to compare the tumor uptake versus time and the tumor response in nude mice transplanted with a human midgut carcinoid (GOT1), when treated with either [(177)Lu-DOTA(0),Tyr(3)]-octreotide or [(177)Lu-DOTA(0),Tyr(3)]-octreotate and to evaluate if plasma chromogranin A (P-CgA) was a reliable marker of tumor response. The tumor uptake and retention of activity of a single intravenous (i.v.) dose (15 MBq) of [(177)Lu-DOTA(0),Tyr(3)]-octreotate or [(177)Lu-DOTA(0),Tyr(3)]-octreotide were compared in nude mice xenografted with GOT1. The activity concentration 24 hours after injection was significantly higher in animals given [(177)Lu-DOTA(0),Tyr(3)]-octreotate versus [(177)Lu-DOTA(0),Tyr(3)]-octreotide (16%+/-1.4% of injected activity per gram [%IA/g] vs. 8.1%+/-2.1% IA/g, mean +/- standard error of the mean) (p=0.00061). The mean absorbed dose was higher in animals given [(177)Lu-DOTA(0),Tyr(3)]-octreotate (46+/-4.3 vs. 17 +/- 3.4 Gy). The reduction of tumor volume was accordingly more prominent in animals given [(177)Lu-DOTA(0),Tyr(3)]-octreotate than in animals given [(177)Lu-DOTA(0),Tyr(3)]-octreotide (p=0.003). The mean tumor volume for animals given [(177)Lu-DOTA(0),Tyr(3)]-octreotate was reduced to 3% of its initial value. P-CgA values were strongly correlated with tumor volume. Octreotate seems to be a more suitable somatostatin analog than octreotide for receptor-mediated radiation therapy. P-CgA is a simple, accurate method for the estimation of tumor response in this animal model.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?